Hosted on MSN29d
Immunity against seasonal H1N1 flu reduces bird flu severity in ferrets, study suggests
Pre-existing immunity against seasonal H1N1 flu might help explain why most reported human cases of H5N1 bird flu in the U.S. have not resulted in lethal outcomes, suggests a new study by ...
If bird flu jumps to humans, immunity from seasonal flu may offer some protection
Very few humans have gone up against bird flu. But we've all dealt with seasonal flu for years. Some of our immune systems ...
CIDRAP7d
CDC confirms D1.3 genotype in recent H5N1 case in Ohio
In an update yesterday on scientific investigations related to H5N1 avian flu activity, the Centers for Disease Control and ...
Nasdaq25d
Traws Pharma, Inc. Reports Positive Topline Results from Ferret Studies on Tivoxavir Marboxil for H5N1 Bird Flu Treatment
Traws Pharma, Inc. reported positive topline results from studies involving ferrets treated with tivoxavir marboxil for H5N1 bird flu, indicating significant suppression of disease and reduced ...
Traws Pharma announces results from study of tivoxavir marboxil in bird flu
Traws Pharma (TRAW) announced topline results from a study evaluating the use of tivoxavir marboxil as a treatment for non-human primates ...
Traws Pharma Antiviral Bird Flu Program, Tivoxavir Marboxil, Shows Positive Data in Non-human Primates
Tivoxavir marboxil (TXM), administered as a single dose in non-human primates, significantly reduced lung viremia and prevented weight loss, two ...